The shares were down 15% after disappointing earnings, although revenue growth was very brisk and the shares quickly recovered. The 2019 revenue guidance is disappointing, but there is the potential for growth further down the line, especially in their indirect hearing aid channel. There is a considerable amount of investment taking place to gear up […]
February 25th, 2019 · Comments Off on IntriCon’s Guidance Disappoints, But There Is Significant Potential Still
December 4th, 2018 · Comments Off on Gravity Gets Hold Of IntriCon – A Buying Opportunity?
The shares have fallen back over 50% of their summer heights. What’s going on? Q3 revenues were off only fractionally, but revenue growth slowed down quite a bit sequentially and its direct hearing aid sell segment actually declined. The company also embarked on a substantial share offering, which board and management used to lighten up […]
August 17th, 2018 · Comments Off on IntriCon Goes Parabolic On The Coatails Of Medtronic
The shares of IntriCon have gone parabolic, and it’s not hard to see why. The main driver is the rapid increase in sales to Medtronic’s continuing glucose monitoring systems, and the end is not in sight here. But the company has other interesting opportunities as well. The shares need a little consolidation and digestion of […]